These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
546 related items for PubMed ID: 27588477
1. eIF4E promotes tumorigenesis and modulates chemosensitivity to cisplatin in esophageal squamous cell carcinoma. Liu T, Li R, Zhao H, Deng J, Long Y, Shuai MT, Li Q, Gu H, Chen YQ, Leng AM. Oncotarget; 2016 Oct 11; 7(41):66851-66864. PubMed ID: 27588477 [Abstract] [Full Text] [Related]
2. Increased expression of EIF5A2, via hypoxia or gene amplification, contributes to metastasis and angiogenesis of esophageal squamous cell carcinoma. Li Y, Fu L, Li JB, Qin Y, Zeng TT, Zhou J, Zeng ZL, Chen J, Cao TT, Ban X, Qian C, Cai Z, Xie D, Huang P, Guan XY. Gastroenterology; 2014 Jun 11; 146(7):1701-13.e9. PubMed ID: 24561231 [Abstract] [Full Text] [Related]
3. Targeting MCL-1 sensitizes human esophageal squamous cell carcinoma cells to cisplatin-induced apoptosis. Yu X, Li W, Xia Z, Xie L, Ma X, Liang Q, Liu L, Wang J, Zhou X, Yang Y, Liu H. BMC Cancer; 2017 Jun 28; 17(1):449. PubMed ID: 28659182 [Abstract] [Full Text] [Related]
4. RFT2 is overexpressed in esophageal squamous cell carcinoma and promotes tumorigenesis by sustaining cell proliferation and protecting against cell death. Jiang XR, Yu XY, Fan JH, Guo L, Zhu C, Jiang W, Lu SH. Cancer Lett; 2014 Oct 10; 353(1):78-86. PubMed ID: 25045844 [Abstract] [Full Text] [Related]
5. Silencing HMGN5 suppresses cell growth and promotes chemosensitivity in esophageal squamous cell carcinoma. Liu X, Ma W, Yan Y, Wu S. J Biochem Mol Toxicol; 2017 Dec 10; 31(12):. PubMed ID: 28914995 [Abstract] [Full Text] [Related]
6. Apollon modulates chemosensitivity in human esophageal squamous cell carcinoma. Zhang S, Tang W, Weng S, Liu X, Rao B, Gu J, Chen S, Wang Q, Shen X, Xue R, Dong L. Oncotarget; 2014 Aug 30; 5(16):7183-97. PubMed ID: 25216531 [Abstract] [Full Text] [Related]
7. Knockdown of frizzled-7 inhibits cell growth and metastasis and promotes chemosensitivity of esophageal squamous cell carcinoma cells by inhibiting Wnt signaling. Liu X, Yan Y, Ma W, Wu S. Biochem Biophys Res Commun; 2017 Aug 26; 490(3):1112-1118. PubMed ID: 28669726 [Abstract] [Full Text] [Related]
8. lncRNA CCAT1 is a biomarker for the proliferation and drug resistance of esophageal cancer via the miR-143/PLK1/BUBR1 axis. Hu M, Zhang Q, Tian XH, Wang JL, Niu YX, Li G. Mol Carcinog; 2019 Dec 26; 58(12):2207-2217. PubMed ID: 31544294 [Abstract] [Full Text] [Related]
9. Metformin inhibited esophageal squamous cell carcinoma proliferation in vitro and in vivo and enhanced the anti-cancer effect of cisplatin. Wang F, Ding X, Wang T, Shan Z, Wang J, Wu S, Chi Y, Zhang Y, Lv Z, Wang L, Fan Q. PLoS One; 2017 Dec 26; 12(4):e0174276. PubMed ID: 28406985 [Abstract] [Full Text] [Related]
15. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells. Dong K, Wang R, Wang X, Lin F, Shen JJ, Gao P, Zhang HZ. Breast Cancer Res Treat; 2009 Feb 26; 113(3):443-56. PubMed ID: 18327707 [Abstract] [Full Text] [Related]
16. Role of Smac in determining the chemotherapeutic response of esophageal squamous cell carcinoma. Xu Y, Zhou L, Huang J, Liu F, Yu J, Zhan Q, Zhang L, Zhao X. Clin Cancer Res; 2011 Aug 15; 17(16):5412-22. PubMed ID: 21676925 [Abstract] [Full Text] [Related]
19. Luteolin enhances drug chemosensitivity by downregulating the FAK/PI3K/AKT pathway in paclitaxel‑resistant esophageal squamous cell carcinoma. Yang Z, Liu H, Song Y, Gao N, Gao P, Hui Y, Li Y, Fan T. Int J Mol Med; 2024 Sep 15; 54(3):. PubMed ID: 38994756 [Abstract] [Full Text] [Related]